⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of EPS Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
EPS Corporation
↗Shinjuku-ku, Tokyo, Japan
EPS Corporation is a prominent Japanese Contract Research Organization (CRO) and a core entity within the EPS Group. Founded in 1991, the company provides a comprehensive suite of services for pharmaceutical, medical device, and regenerative medicine development, including clinical trial planning, data management, statistical analysis, and regulatory consulting.
Beyond traditional CRO services, EPS has evolved into a 'Gateway' provider, facilitating market entry and clinical development for foreign biotech companies in Japan and Asia. The group operates under a holding company structure (EPS Holdings, Inc.) and maintains a strong presence in Japan, China, and other Asia-Pacific markets, focusing on addressing 'drug lag' and 'drug loss' through innovative research and digital health solutions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1991
Ownership:subsidiary
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Small molecule, Regenerative medicine, Vaccines
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:EPNextS, Inc. (part of EPS Holdings, Inc.)
Subsidiaries:EP-PharmaLine Co., Ltd., EP Mediate Co., Ltd., EP-Bio Partners Co., Ltd.
Key Partnerships:Frontage Laboratories (Early-phase clinical trial collaboration), Suzuken Group (Drug distribution and market access), MICIN (Virtual clinical trials)
COMPETITION
Position:Leader
Competitors:Parexel, Syneos Health, TFS
LEADERSHIP
Key Executives:
Noriyuki Takai - Representative Director & President
LINKS
Website:eps.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EPS Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.